4/6
03:40 am
prpo
Precipio GAAP EPS of -$0.23, revenue of $24.05M [Seeking Alpha]
Low
Report
Precipio GAAP EPS of -$0.23, revenue of $24.05M [Seeking Alpha]
4/4
01:04 am
prpo
Low
Report
4/2
07:07 pm
prpo
Precipio, Inc. (PRPO) Q4 2025 Earnings Call Prepared Remarks Transcript [Seeking Alpha]
Low
Report
Precipio, Inc. (PRPO) Q4 2025 Earnings Call Prepared Remarks Transcript [Seeking Alpha]
3/22
01:04 am
prpo
Medium
Report
3/12
05:00 pm
prpo
Precipio Announces Q4 and year-end 2025 Shareholder Update Call
Medium
Report
Precipio Announces Q4 and year-end 2025 Shareholder Update Call
3/10
09:00 am
prpo
Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay
Medium
Report
Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay
2/25
09:56 am
prpo
Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year [Yahoo! Finance]
Medium
Report
Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year [Yahoo! Finance]
2/25
09:30 am
prpo
Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year
Medium
Report
Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year